Cedars-Sinai investigators may have figured out why certain immunosuppressive treatments don't work well in rheumatoid ...

DEAR DR. ROACH: Why doesn’t rheumatoid arthritis have any medicines to help treat it? — S.S.K. ANSWER: Rheumatoid arthritis is relatively common (as much as 1% of the population, with women twice as ...

Rheumatoid arthritis treatment aims to reduce inflammation, relieve pain, and preserve joint function through biologics, DMARDs, physical therapy, lifestyle changes, and sometimes surgery. Advances in ...

Rheumatoid arthritis (RA) is a painful joint condition that affects about 1.5 million people in the United States. Pain, tenderness, and stiffness are often the first symptoms of RA and can affect ...

Looking for ways to complement your Rheumatoid Arthritis treatment? Discover expert-backed natural remedies, ...

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

Rheumatoid arthritis is a chronic autoimmune disorder causing inflammation of synovial joints, leading to pain, stiffness, swelling, and deformities. Early diagnosis with tests like RF and anti-CCP, ...

SAN DIEGO — Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful ...

LONDON--(BUSINESS WIRE)--The global rheumatoid arthritis (RA) drugs market 2018-2022 is expected to post a CAGR of close to 8% during the forecast period, according to the latest market research ...

SetPoint therapy is a tiny, pill-sized implant that’s inserted into the body. Metro Phoenix-based Dr. John Tesser served as ...

Dear S.S.K.: Rheumatoid arthritis is relatively common (as much as 1% of the population, with women twice as likely to be affected than men), but it’s a much less common form of arthritis than ...

The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Oct. 7, 2025 /PRNewswire/ -- The global rheumatoid arthritis drugs market was valued at US$31 ...